Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:SM 18:2;O2/24:3)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST003694 AN006061 FOLFIRINOX effects on lipidomics in pancreatic cancer cells Pancreas Human Cancer Pennsylvania State University LC-MS
ST003661 AN006017 Lipidomics facilitates the discovery of diagnostic biomarkers in patients with chronic total occlusion during the perioperative period Blood Human Cardiovascular disease Zhongshan Hospital Fudan University LC-MS
ST003222 AN005283 A small molecule macrophage migration inhibitory factor agonist ameliorates age-related myocardial intolerance to ischemia-reperfusion insults via metabolic regulation - Part 1 Heart Mouse Ischemia University of Mississippi Medical Center LC-MS
ST002283 AN003730 The “ForensOMICS” approach to forensic post-mortem interval estimation: combining metabolomics, lipidomics and proteomics for the analysis human skeletal remains Bone Human University of Central Lancashire LC-MS
  logo